Resolution Biosciences
The firm is expanding its lab capabilities and leveraging its test development reputation to form partnerships early in the drug development process.
Industry insiders said Resolution Bio may be a better fit under Exact Sciences and think it could augment Exact's cancer testing portfolio.
Agilent Technologies Selling Resolution Bioscience to Exact Sciences
The firms announced a deal, for an undisclosed sum, about one month after Agilent announced plans to shutter the Resolution Bioscience business.
For Q3, the firm said its diagnostics revenues rose 3 percent, but Resolution's kitted NGS-based companion diagnostics business hadn't developed as expected.
The firm will build liquid biopsy companion diagnostic tests that complement its tissue-based assays and are tailored for drugs developed by pharma partners.
Mar 29, 2019